ArticleBiomedicines2022

Targeting Tumor Cells Overexpressing the Human Epidermal Growth Factor Receptor 3 with Potent Drug Conjugates Based on Affibody Molecules.

Sara S Rinne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.